Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01356225 · ClinicalTrials.gov registry record · Phase 2

A Single-dose Study of Intranasal Ketorolac in the Treatment of Pain Secondary to Dental Impaction Surgery

A Phase 2 study of Pain and Dental Impaction, sponsored by Egalet.

Completed
Registry status
Phase 2
Development phase
80
Enrollment target
1
Study location

NCT01356225 is a Phase 2 study of Pain and Dental Impaction that has completed, run by Egalet. The registered enrollment target is 80 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01356225, a Phase 2 study of Pain and Dental Impaction, has completed, sponsored by Egalet.

COMPLETED
Registry status
Phase 2
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the analgesic efficacy of a single intranasal (IN) administration of ketorolac after dental impaction surgery.

Conditions Studied

Pain Dental Impaction

Interventions

  • DRUG Placebo
  • DRUG Ketorolac tromethamine

Study Locations (1)

Texas

  • Austin Oral Surgery - PPD Development - Austin

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2004-02
Phase Phase 2

Sponsor

Egalet

5 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01356225

The ClinicalTrials.gov registry entry for NCT01356225 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (74% lower). The listed sponsor is Egalet, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT01356225 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT01356225 about?

NCT01356225 is a clinical study titled "A Single-dose Study of Intranasal Ketorolac in the Treatment of Pain Secondary to Dental Impaction Surgery". The purpose of this study is to evaluate the analgesic efficacy of a single intranasal (IN) administration of ketorolac after dental impaction surgery.

What is the current status of trial NCT01356225?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 80 participants. The study started on 2004-02.

What conditions does trial NCT01356225 study?

This clinical trial studies the following conditions: Pain, Dental Impaction.

What interventions are being tested in trial NCT01356225?

The interventions under investigation include: Placebo (DRUG), Ketorolac tromethamine (DRUG).

Who is sponsoring clinical trial NCT01356225?

This trial is sponsored by Egalet, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01356225 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Pain

All registered trials for this condition

Dental Impaction

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.